Product Overview

Papaverine 30 mg is a prescription injectable medication formulated for the treatment of erectile dysfunction in adult men. The product is manufactured by Vulcan Laboratories Pvt Ltd and is supplied in a 2 ml ampoule that contains 30 mg of the active ingredient papaverine. Depending on the packaging option, patients can purchase the medication in pack sizes of ten, twenty, or forty ampoules, allowing for flexible treatment plans that match individual needs. Orders are typically processed and shipped within a window of six to fifteen days after confirmation, and the medication is delivered directly to the patient’s address in a discreet, secure package. This overview introduces the key attributes of the product, including its indication, strength, manufacturer, and packaging, and sets the stage for a deeper exploration of its therapeutic use, safety considerations, and practical guidance for appropriate administration.

What is Papaverine

Papaverine belongs to a class of vascular smooth‑muscle relaxants that are used clinically to facilitate erection by increasing blood flow to the penile tissue. Although it shares some pharmacological properties with other phosphodiesterase inhibitors, papaverine acts primarily by elevating intracellular cyclic adenosine monophosphate (cAMP) levels, which leads to relaxation of the trabecular smooth muscle and subsequent engorgement of the corpora cavernosa. The drug has a long history of medical use, dating back several decades, and its safety profile has been documented in peer‑reviewed studies and regulatory submissions. For a comprehensive scientific perspective, reputable sources such as the National Institutes of Health National Institutes of Health and the United States Food and Drug Administration FDA provide detailed information on pharmacology, clinical trial results, and approved indications.

Uses and Benefits

The primary clinical indication for papaverine 30 mg injection is the management of erectile dysfunction, especially in situations where oral therapies are ineffective, contraindicated, or not well tolerated. Administered directly into the penile tissue, the medication bypasses gastrointestinal absorption and achieves rapid onset of action, typically within five to ten minutes after injection. Patients often report improved erectile rigidity, increased sexual confidence, and the ability to achieve erections that are suitable for intercourse without the need for systemic oral medication. Additionally, the injectable route can be advantageous for individuals with hepatic impairment or those taking medications that interact with oral phosphodiesterase inhibitors, as it avoids first‑pass metabolism and reduces the likelihood of systemic drug interactions.

How It Works

Following administration, papaverine exerts its therapeutic effect by inhibiting phosphodiesterase activity within penile smooth muscle cells, which results in an accumulation of cyclic adenosine monophosphate (cAMP). The rise in cAMP triggers relaxation of the trabecular smooth muscle, leading to dilation of penile arterial inflow and engorgement of the corpora cavernosa. This physiological cascade culminates in a firm erection that can be sustained for several minutes to an hour, depending on individual metabolic factors and the dose administered. Understanding this mechanism of action enables healthcare providers to tailor dosing regimens, monitor therapeutic response, and manage expectations regarding onset, duration, and overall efficacy.

Dosage Guidelines

The standard dosing regimen for papaverine 30 mg injection involves the use of a single 2 ml ampoule administered into the lateral aspect of the penis prior to sexual activity. The recommended dose is one ampoule, and the medication should not be used more frequently than once every 24 hours. Clinicians typically advise patients to begin with the lowest effective dose and to adjust only under the supervision of a qualified healthcare professional. To minimize the risk of tissue irritation or fibrosis, injection sites should be rotated with each administration, and the procedure should be performed using a sterile technique. For patients with special populations, such as those with renal or hepatic impairment, dose modifications may be necessary, and a thorough medical evaluation is recommended before initiating therapy.

Side Effects

As with any pharmaceutical agent, papaverine can produce adverse effects, although many are mild and self‑limiting. The most commonly reported side effects include localized penile pain, transient dizziness, headache, and mild cardiovascular responses such as tachycardia. In some cases, patients may experience prolonged erection (priapism), which requires immediate medical attention to prevent permanent tissue damage. Less frequent but more serious adverse events can include fibrosis, penile curvature, or systemic reactions such as nausea and vomiting. Patients are encouraged to report any unexpected or concerning symptoms to their physician promptly. Detailed safety data and adverse event reporting can be accessed through authoritative health portals such as MedlinePlus MedlinePlus, which provides up‑to‑date information on drug‑related concerns.

Warnings and Precautions

Several important warnings and precautions should be observed before using papaverine. The medication is contraindicated in individuals with a known hypersensitivity to papaverine or any excipients present in the formulation. Caution is advised in patients with a history of cardiovascular disease, severe hepatic impairment, or structural abnormalities such as Peyronie’s disease. Concomitant use of other vasodilatory agents or medications that lower blood pressure may increase the risk of hypotension, and therefore a thorough medication review is essential. Patients who have recently undergone genital surgery, have active infections, or possess anatomical abnormalities should consult a healthcare provider before initiating treatment. Finally, it is imperative that all patients discuss their complete medical history, current medication list, and any underlying health conditions with a qualified clinician to ensure safe and appropriate use.

Frequently Asked Questions

What is the typical onset time after injection?

Most men achieve an erection within five to ten minutes after the injection, although individual response can vary based on dosage, vascular health, and metabolic factors.

Can papaverine be used together with oral erectile dysfunction medications?

Combining papaverine with oral phosphodiesterase type 5 inhibitors is generally discouraged because it may increase the risk of priapism and excessive vasodilation, potentially leading to unsafe drops in blood pressure.

Is the medication safe for men with diabetes?

Papaverine can be used in diabetic patients, but caution is warranted due to the higher prevalence of vascular complications; a physician should evaluate each case individually to determine suitability.

How should the injection be stored before use?

The ampoules should be stored refrigerated at a temperature between 2 and 8 degrees Celsius and protected from light; once an ampoule is opened, the contents should be used immediately and any unused portion discarded according to local regulations.

What should I do if an erection lasts longer than four hours?

If an erection persists for more than four hours, seek emergency medical care without delay, as prolonged priapism can cause permanent damage to penile tissue.

Related Products

• Sildenafil Oral Disintegrating Strips
• Siezta 100 Mg (Sildenafil Citrate)
• Orgie 20 Mg (Tadalafil)
• Vega Polo (Sildenafil Citrate)
• Filagra FXT Plus (Sildenafil Citrate/Fluoxetine)
• Sildigra Soft 100 mg (Sildenafil Citrate)
• Filagra DXT Plus (Sildenafil Citrate/Duloxetine)
• Sildigra XL Plus 150 mg (Sildenafil Citrate)
• Filagra Oral Jelly (Sildenafil Citrate)
• Modula 5 mg (Tadalafil)
• Sildigra Gold 200 mg (Sildenafil Citrate)
• Sildigra 120 mg (Sildenafil Citrate)